This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

WCLC, Barcelona, Spain 7-10 September 2019

Afatinib in EGFR mutation-positive NSCLC: Activity in patients with brain metastases, and impact on CNS progression/spread

Kenneth O’Byrne, James Chih-Hsin Yang, Yi-Long Wu, Vera Hirsh, Nobuyuki Yamamoto, Sanjay Popat, Akihiro Tamiya, Angela Märten, Martin Schuler

wclc_2019_cns.jpg

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

BRAIN METASTASES

Go To Page

FOR HEALTHCARE PROFESSIONALS ONLY.

image